Skip to main content

Table 1 Comparison of general information after matching of propensity scores of early breast cancer patients with different surgical treatments

From: Cost-effectiveness of different surgical treatment approaches for early breast cancer: a retrospective matched cohort study from China

   MAST+
RECON
(n = 205)
BCT
(n = 205)
MAST
(n = 205)
p value
   No.(%) No.(%) No.(%)  
Age,year   38.63
±6.94
38.60
±7.58
39.03
±7.21
0.801
Health-care insurance Provincial medical insurance 13 (6.34) 12 (5.85) 11 (5.37) 0.359
City medical insurance 102 (49.76) 100 (48.78) 119 (58.05)  
Other 90 (43.90) 93 (45.37) 75 (36.59)  
Lesion location Left breast 110 (53.66) 112 (54.63) 109 (53.17) 0.687
Right breast 95 (46.34) 93 (45.37) 95 (46.34)  
Double breast 0 (0.00) 0 (0.00) 1 (0.49)  
Histology type Ductal carcinoma in situ 10 (4.88) 5 (2.44) 6 (2.93) 0.692
Invasive ductal carcinoma 158 (77.07) 168 (81.95) 164 (80.00)  
Invasive lobular carcinoma 5 (2.44) 3 (1.46) 2 (0.98)  
Other 32 (15.61) 29 (14.15) 33 (16.10)  
TNM stage 0 4 (1.95) 3 (1.46) 7 (3.41) 0.513
I 6 (2.93) 5 (2.44) 6 (2.93)  
II 195 (95.12) 197 (96.10) 192 (93.66)  
BMI,Kg/m2 <18.5 21 (10.24) 15 (7.32) 15 (7.32) 0.261
18.5 ~ 23.9 144 (70.24) 164 (80.00) 148 (72.20)  
>23.9 40 (19.51) 26 (12.68) 42 (20.49)  
Hormone receptor Positive 105 (51.22) 106 (51.71) 195 (66.10) 0.993
Negative 19 (9.27) 17 (8.29) 21 (7.12)  
Mixed 73 (35.61) 75 (36.59) 73 (24.75)  
Unkonwn / missing 8 (3.90) 7 (3.41) 6 (2.03)  
Patient source In this city 126 (61.46) 129 (62.93) 131 (63.90) 0.899
In this province 71 (34.63) 65 (31.71) 66 (32.20)  
Other 8 (3.90) 11 (5.37) 8 (3.90)  
Neoadjuvant chemotherapy No 165 (80.49) 169 (82.44) 169 (82.44) 0.840
Yes 40 (19.51) 36 (17.56) 36 (17.56)  
Targeted therapy No 167 (81.46) 172 (83.90) 171 (83.41) 0.786
Yes 38 (18.54) 33 (16.10) 34 (16.59)  
  1. Abbreviations: MAST + RECON Mastectomy with reconstruction; BCT Breast-conserving therapy; MAST Mastectomy